Wilmington Trust’s Elevance Health ELV Stock Holding History

Wilmington Trust’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$244K	Buy	+2,263	New	+$233K	﹤0.01%	662

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wilmington Trust's ELV Position: Q2 2014 in Review

Wilmington Trust opened a new position in Elevance Health (ELV) in Q2 2014: 2,263 shares worth $244K. The stake represents ﹤0.01% of the portfolio and ranks #662 among its holdings.

686 funds tracked by Wall St. Rank hold ELV as of Q2 2014.

Wilmington Trust held 2,263 shares of Elevance Health worth $244K as of Q2 2014.
Elevance Health was a new Wilmington Trust position in Q2 2014.
Elevance Health made up ﹤0.01% of Wilmington Trust's portfolio in Q2 2014, its #662 holding.
686 funds tracked by Wall St. Rank held Elevance Health as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.